feed,title,long_url,short_url
Benzinga,European Patent Office rules in favor of Sanofi and Regeneron concerning PraluentÂ® (alirocumab),https://www.benzinga.com/pressreleases/20/10/g18120423/european-patent-office-rules-in-favor-of-sanofi-and-regeneron-concerning-praluent-alirocumab,https://j.mp/3jG09p2
